(Q51989974)

19 April 2018

title

Immunogenicity and immunological memory induced by a 7-valent pneumococcal CRM197 conjugate vaccine in symptomatic HIV-1 infected children. (English)

1 reference

19 April 2018

1 reference

1 reference

Vana I Spoulou

1

1 reference

19 April 2018

Dimitris L Tsoumas

2

1 reference

19 April 2018

Vana G Papaevangelou

3

1 reference

19 April 2018

Glykeria I Mostrou

4

1 reference

19 April 2018

Maria C Theodoridou

5

1 reference

19 April 2018

language of work or name

English

0 references

publication date

21 June 2005

1 reference

19 April 2018

number of pages

5

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

19 April 2018

volume

23

1 reference

19 April 2018

issue

46-47

1 reference

19 April 2018

page(s)

5289-5293

1 reference

19 April 2018

A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.002

Serological criteria for evaluation and licensure of new pneumococcal conjugate vaccine formulations for use in infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.002

Antibody avidity as a surrogate marker of successful priming by Haemophilus influenzae type b conjugate vaccines following infant immunization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.002

23-valent pneumococcal vaccination and HIV

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.002

Pneumococcal type 22f polysaccharide absorption improves the specificity of a pneumococcal-polysaccharide enzyme-linked immunosorbent assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.002

Multistate evaluation of invasive pneumococcal diseases in adults with human immunodeficiency virus infection: serotype and antimicrobial resistance patterns in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.002

Randomized trial of the quantitative and functional antibody responses to a 7-valent pneumococcal conjugate vaccine and/or 23-valent polysaccharide vaccine among HIV-infected adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.002

Natural and vaccine-induced immunity and immunologic memory to Neisseria meningitidis serogroup C in young adults.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.002

Differences in the avidity of antibodies evoked by four different pneumococcal conjugate vaccines in early childhood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.002

Immunogenetic analysis of the immune response to pneumococcal polysaccharide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.002

Tolerability and immunogenicity of an 11-valent pneumococcal conjugate vaccine in adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.002

Haemophilus influenzae type b conjugate vaccine-induced immunological memory in symptomatic HIV-1-infected children.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.002

Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate Vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.002

10.1016/J.VACCINE.2005.06.002

7 January 2021

Identifiers

DOI

1 reference

19 April 2018

1 reference

19 April 2018